Kevin Michael Donahue is 10% at MAINZ BIOMED N.V. (MYNZ). They have made 1 open-market trade across 1 company since 2025, most recently 2025-10-17.
CIK 0002105585
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $1.0M since 2025, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MYNZ | 685,000 | — |
Shares reported on the most recent Form 4, priced at the 2026-01-20 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MYNZ | BUY | 2025-10-17 | 2026-01-20 | $1.51 | $1.0M | N/A | N/A | N/A |